Clinical Trial Update: Xanthine Oxidase Inhibition in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigating xanthine oxidase inhibition in renal transplant recipients was terminated; results were posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplant Complications

Snippet

Sponsor: Roberto S Kalil | Conditions: Complications of Renal Transplant | Phase 4 | Status: TERMINATED | Results posted: 2019-10-15